Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates

Urology

Volumn 68, Issue 4, 2006, Pages 784-789

  Kok, Esther T ^a   Bohnen, Arthur M ^a   Jonkheijm, Rikkert ^a   Gouweloos, Jochem ^a   Groeneveld, Frans P M J ^a   Thomas, Siep ^a   Bosch, J L H Ruud ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; CLINICAL FEATURE; CONSULTATION; CONTROLLED STUDY; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE;

AGED; FAMILY PRACTICE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSTATIC HYPERPLASIA; SEVERITY OF ILLNESS INDEX;

EID: 33750347554     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.04.008     Document Type: Article

References (13)

1. Garraway W.M., Collins G.N., and Lee R.J. High prevalence of benign prostatic hypertrophy in the community. Lancet 338 (1991) 469-471
2. In: Chatelain C., Denis L., Foo K.T., et al. (Eds). Proceedings of the Fifth International Consultation on Benign Prostatic Hyperplasia (BPH) (2001), SCI, Paris 112-114
3. Blanker M.H., Groeneveld F.P., Prins A., et al. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int 85 (2000) 665-671
4. Barry M.J., Fowler F.J., O'Leary M.P., et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 148 (1992) 1549-1557
5. Bosch J., Bohnen A., Groeneveld F., et al. Validity of three caliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: the Krimpen Study. Prostate 62 (2005) 353-363
6. Bosch J.L., Hop W.C., Kirkels W.J., et al. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community. Urology 46 (1995) 34-40
7. Clifford G.M., Logie J., and Farmer R.D. How do symptoms indicative of BPH progress in real life practice?. The UK experience. Eur Urol 38 suppl 1 (2000) 48-53
8. Verhamme K.M., Dieleman J.P., Bleumink G.S., et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care-the Triumph project. Eur Urol 42 (2002) 323-328
9. Wolfs G.G., Knottnerus J.A., and Janknegt R.A. Prevalence and detection of micturition problems among 2,734 elderly men. J Urol 152 (1994) 1467-1470
10. Lowe F.C., Batista J., Berges R., et al. Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion. Prostate Cancer Prostatic Dis 8 (2005) 206-209
11. Kok E.T., Groeneveld F.P.M.J., Gouweloos J., et al. Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men. Eur Urol (2006) (in press)
12. Wolters R., Wensing M., van Weel C., et al. Lower urinary tract symptoms: social influence is more important than symptoms in seeking medical care. BJU Int 90 (2002) 655-661
13. Cunningham-Burley S., Allbutt H., Garraway W.M., et al. Perceptions of urinary symptoms and health-care-seeking behaviour amongst men aged 40-79 years. Br J Gen Pract 46 (1996) 349-352